Loading rounds…
Loading rounds…
Explore funding rounds, the companies behind them and the investors taking part.
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
| 4B 4Moving BiotechCompany profile Developing disease-modifying osteoarthritis drug for knee osteoarthritis Developing disease-modifying osteoarthritis drug for knee osteoarthritis | €12M | Series A | Biotech | France | Investors Undisclosed | |
| A ArrayPatchCompany profile Develops microneedle-based therapeutics for treatment of nail fungus and other diseases Develops microneedle-based therapeutics for treatment of nail fungus and other diseases | €3M | Seed | Biotech, Healthtech |
Ranked by rounds participated in · All time
AusperBio, Abcuro, Infinimmune
Epicrispr Biotechnologies, Draig Therapeutics, Triveni Bio
LifeMine Therapeutics, Ollin Biosciences, SonoThera
Leal Therapeutics, Khartis Therapeutics, Vedana Therapeutics
Leal Therapeutics, Amplifica Holdings Group, InduPro
Explore published rounds while the next edition is being prepared.
| Ireland |
| Investors |
| IB Developing a next-generation pertussis vaccine candidate BPZE1 | $115M | Series B | Biotech | United States | Investors |
| PT Pandorum TechnologiesCompany profile Develops tunable, regenerative exosome therapies for tissue health, disease, and degeneration Develops tunable, regenerative exosome therapies for tissue health, disease, and degeneration | $18M | Series B | Biotech | India | Investors |
| G GaluxCompany profile Develops AI-driven protein design platform for de novo antibody and drug discovery Develops AI-driven protein design platform for de novo antibody and drug discovery | $29M | Series B | Biotech | South Korea | Investors |
| TA Third Arc BioCompany profile Develops novel multifunctional antibodies for oncology and immunology & inflammation indications Develops novel multifunctional antibodies for oncology and immunology & inflammation indications | $52M | Series A+Series A | Biotech | United States | Investors |
| ES Provides scalable cultivated real beef into existing systems | $6M | Undisclosed | Biotech, Foodtech | United States | Investors |
| QS Develops quantum-based platform for real-time cell analysis | €4M | Seed | Biotech | Netherlands | Investors |
| b Physician-led preventive care platform using AI for early cancer detection | $4M | Seed | Biotech, Healthtech | United States | Investors |
| EB Develops sustainable high-performance biopolymer ingredients | Undisclosed | Series B | Biotech | United States | Investors |